Investigating how certain stem cells evade the immune system in the bone marrow
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells
This study is looking at how certain areas in the bone marrow help protect blood stem cells from the immune system, which could lead to better treatments for blood cancers and improve outcomes for people getting stem cell transplants.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10990503 on NIH RePORTER |
What this research studies
This research explores the immune properties of hematopoietic stem cell (HSC) niches in the bone marrow, focusing on how these niches may protect stem cells from immune attacks. The study examines the role of regulatory T cells (Tregs) in maintaining this immune privilege, which could allow for better outcomes in stem cell transplantation and cancer therapies. By understanding the mechanisms that enable HSCs and leukemic stem cells to persist in the presence of an immune response, the research aims to identify new strategies for enhancing the effectiveness of anti-cancer therapies. Patients may benefit from insights that could lead to improved treatments for blood cancers and better transplant outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients undergoing stem cell transplantation or those with blood cancers such as leukemia.
Not a fit: Patients with solid tumors or those not requiring stem cell therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and improved success rates for stem cell transplants.
How similar studies have performed: Previous research has shown promise in understanding immune privilege in other stem cell niches, suggesting potential for success in this area as well.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Fujisaki, Joji — Beth Israel Deaconess Medical Center
- Study coordinator: Fujisaki, Joji
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.